Literature DB >> 7533025

E-selectin polymorphism and atherosclerosis: an association study.

K Wenzel1, S Felix, F X Kleber, R Brachold, T Menke, S Schattke, K L Schulte, C Gläser, K Rohde, G Baumann.   

Abstract

Adhesion molecules like the members of the selectin family participate in the interaction between leukocytes and the endothelium. They are also involved in the pathogenesis of atherosclerotic processes. To contribute to the analysis of the genetic background of atherosclerosis we searched for DNA polymorphisms in the genes encoding adhesion molecules especially E-selectin which seems to be expressed only in activated endothelium. An adenine to cytosine substitution for cDNA position 561 resulting in an amino acid exchange from serine to arginine (position 128) was detected in the epidermal growth factor like domain. A significantly higher mutation frequency (P = 0.02) was observed in 97 patients aged 50 years or less with angiographically proven severe atherosclerosis (allele frequency of arginine 0.155) compared with an unselected population (allele frequency of arginine 0.088) as well as in 40 patients aged 40 years or less (allele frequency of arginine 0.21, P = 0.0025). These data suggest that the 128-serine/arginine polymorphism is associated with a higher risk for early severe atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7533025     DOI: 10.1093/hmg/3.11.1935

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  24 in total

1.  A multilocus genotyping assay for candidate markers of cardiovascular disease risk.

Authors:  S Cheng; M A Grow; C Pallaud; W Klitz; H A Erlich; S Visvikis; J J Chen; C R Pullinger; M J Malloy; G Siest; J P Kane
Journal:  Genome Res       Date:  1999-10       Impact factor: 9.043

Review 2.  Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies.

Authors:  F Andreotti; I Porto; F Crea; A Maseri
Journal:  Heart       Date:  2002-02       Impact factor: 5.994

3.  Variants associated with common disease are not unusually differentiated in frequency across populations.

Authors:  Kirk E Lohmueller; Matthew M Mauney; David Reich; John M Braverman
Journal:  Am J Hum Genet       Date:  2005-11-16       Impact factor: 11.025

4.  Correlation between polymorphisms of the E-selectin gene, hepatitis B virus DNA copies, pre-S1 antigen and clinical outcomes during chronic hepatitis B.

Authors:  Weijuan Cai; Liang Yin; Shaoliang Wang; Yu Wei; Wenjiang Cao; Jiang Cheng
Journal:  Int J Clin Exp Med       Date:  2015-02-15

5.  Functional impact of IgA nephropathy-associated selectin gene haplotype on leukocyte-endothelial interaction.

Authors:  Takashi Takei; Megumi Hiraoka; Kosaku Nitta; Keiko Uchida; Michiyo Deushi; Tao Yu; Noriko Nitta; Ken Tsuchiya; Wako Yumura; Hiroshi Nihei; Yusuke Nakamura; Masayuki Yoshida
Journal:  Immunogenetics       Date:  2006-04-28       Impact factor: 2.846

6.  DNA polymorphisms in adhesion molecule genes--a new risk factor for early atherosclerosis.

Authors:  K Wenzel; M Ernst; K Rohde; G Baumann; A Speer
Journal:  Hum Genet       Date:  1996-01       Impact factor: 4.132

Review 7.  Salt controls endothelial and vascular phenotype.

Authors:  Kristina Kusche-Vihrog; Boris Schmitz; Eva Brand
Journal:  Pflugers Arch       Date:  2014-11-26       Impact factor: 3.657

8.  Genomics: risk and outcomes in cardiac surgery.

Authors:  Tjorvi E Perry; Jochen D Muehlschlegel; Simon C Body
Journal:  Anesthesiol Clin       Date:  2008-09

Review 9.  Targeting selectins and selectin ligands in inflammation and cancer.

Authors:  Steven R Barthel; Jacyln D Gavino; Leyla Descheny; Charles J Dimitroff
Journal:  Expert Opin Ther Targets       Date:  2007-11       Impact factor: 6.902

10.  Effects of TNF-alpha antagonism on E-selectin in obese subjects with metabolic dysregulation.

Authors:  Markella V Zanni; Takara L Stanley; Hideo Makimura; Cindy Y Chen; Steven K Grinspoon
Journal:  Clin Endocrinol (Oxf)       Date:  2010-07       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.